Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study
•First qualitative research of considerations of women after fertility preservation.•Women are strongly motivated to try natural conception after fertility preservation.•Perceived time pressure is an important motivator for embryo transfer.•Wish for pre-implantation genetic testing is a reason for e...
Gespeichert in:
Veröffentlicht in: | European journal of obstetrics & gynecology and reproductive biology 2024-02, Vol.293, p.27-31 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 31 |
---|---|
container_issue | |
container_start_page | 27 |
container_title | European journal of obstetrics & gynecology and reproductive biology |
container_volume | 293 |
creator | ter Welle - Butalid, Maria Elena van Osch, Liesbeth van Bree, Bo E. Vriens, Ingeborg J.H. Derhaag, Josien G. de Die - Smulders, Christine E.M. Tjan - Heijnen, Vivianne C.G. van Golde, Ron J.T. |
description | •First qualitative research of considerations of women after fertility preservation.•Women are strongly motivated to try natural conception after fertility preservation.•Perceived time pressure is an important motivator for embryo transfer.•Wish for pre-implantation genetic testing is a reason for embryo transfer.•Physician’s advice highly influences the decision on mode of conception.
To gain insight into the considerations of breast cancer survivors to return or not for embryo transfer after the use of fertility preservation.
This is a qualitative study with semi-structured interviews. The interviews were planned until saturation of themes had been achieved. Content analysis was used to analyze the data. Sixteen out of 35 approached women took part in this study. Interviews were conducted with women who had oocytes or embryos cryopreserved prior to breast cancer treatment at the Maastricht University Medical Center between 2008 and 2016. All women who had cryopreservation more than two years ago were invited for the interviews. Women who had recurrence of disease were excluded. In the interviews we hypothesized the situation ‘suppose the menses would have been recovered completely’ for women who still had chemotherapy-induced menopause or used an GnRH (Gonadotropin-releasing hormone) analogue.
Most women had a strong intrinsic motivation to pursue natural conception over the use of earlier cryopreserved oocytes or embryos. Time pressure was the most mentioned consideration to use cryopreserved oocytes or embryos. The wish to use pre-implantation genetic testing (PGT) in the presence of a germline BRCA1/2 mutation was another consideration to opt for embryo transfer. Furthermore, the physician’s advice was an important motivation to choose for either natural conception or the use of cryopreserved oocytes or embryos.
Multiple considerations influence women’s decision making on the mode of conception after breast cancer. Although it concerned a single-center study in a highly-selected population, insight into these considerations can help physicians to address these important topics in counseling these women. |
doi_str_mv | 10.1016/j.ejogrb.2023.12.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2902967284</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211523008539</els_id><sourcerecordid>2902967284</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-10b82e4b652c7f50eb0621d166189559acd403a4aa870503456b3f20349c1df23</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVISTbb_IMQdMzFrj4sf-QQCEubFgK9tGchy6OgZdfajGSD_3203aTH6CC9Es_MoIeQG85Kznj9bVvCNrxgXwomZMlFyVh3Rla8bUTR1Ko6JysmGS8E5-qSXMW4ZXlJ2V2QS9nyTMt2RZZNGKMfAE3yOdHgaI9gYqLWjBaQxglnPweMNAWKkCYcqQtIYd_jEmhCM0aXOeNS3nNKfufTQg8IEXD-1_aePtLXyeT3fJ2BxjQNy1fyxZldhOv3c03-_vj-Z_OzeP799Gvz-FxYqZpUcNa3Aqq-VsI2TjHoWS34wOuat51SnbFDxaSpjGkbppisVN1LJ3LoLB-ckGtyd-p7wPA6QUx676OF3c6MEKaoRcdEVzeirTJanVCLIUYEpw_o9wYXzZk-StdbfZKuj9I1F_qocU1u3ydM_R6G_0UfljPwcAIg_3P2gDpaD1nv4BFs0kPwn094A7LYls4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902967284</pqid></control><display><type>article</type><title>Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>ter Welle - Butalid, Maria Elena ; van Osch, Liesbeth ; van Bree, Bo E. ; Vriens, Ingeborg J.H. ; Derhaag, Josien G. ; de Die - Smulders, Christine E.M. ; Tjan - Heijnen, Vivianne C.G. ; van Golde, Ron J.T.</creator><creatorcontrib>ter Welle - Butalid, Maria Elena ; van Osch, Liesbeth ; van Bree, Bo E. ; Vriens, Ingeborg J.H. ; Derhaag, Josien G. ; de Die - Smulders, Christine E.M. ; Tjan - Heijnen, Vivianne C.G. ; van Golde, Ron J.T.</creatorcontrib><description>•First qualitative research of considerations of women after fertility preservation.•Women are strongly motivated to try natural conception after fertility preservation.•Perceived time pressure is an important motivator for embryo transfer.•Wish for pre-implantation genetic testing is a reason for embryo transfer.•Physician’s advice highly influences the decision on mode of conception.
To gain insight into the considerations of breast cancer survivors to return or not for embryo transfer after the use of fertility preservation.
This is a qualitative study with semi-structured interviews. The interviews were planned until saturation of themes had been achieved. Content analysis was used to analyze the data. Sixteen out of 35 approached women took part in this study. Interviews were conducted with women who had oocytes or embryos cryopreserved prior to breast cancer treatment at the Maastricht University Medical Center between 2008 and 2016. All women who had cryopreservation more than two years ago were invited for the interviews. Women who had recurrence of disease were excluded. In the interviews we hypothesized the situation ‘suppose the menses would have been recovered completely’ for women who still had chemotherapy-induced menopause or used an GnRH (Gonadotropin-releasing hormone) analogue.
Most women had a strong intrinsic motivation to pursue natural conception over the use of earlier cryopreserved oocytes or embryos. Time pressure was the most mentioned consideration to use cryopreserved oocytes or embryos. The wish to use pre-implantation genetic testing (PGT) in the presence of a germline BRCA1/2 mutation was another consideration to opt for embryo transfer. Furthermore, the physician’s advice was an important motivation to choose for either natural conception or the use of cryopreserved oocytes or embryos.
Multiple considerations influence women’s decision making on the mode of conception after breast cancer. Although it concerned a single-center study in a highly-selected population, insight into these considerations can help physicians to address these important topics in counseling these women.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2023.12.009</identifier><identifier>PMID: 38100938</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Breast cancer ; Considerations ; Evaluation ; Fertility preservation</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 2024-02, Vol.293, p.27-31</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c357t-10b82e4b652c7f50eb0621d166189559acd403a4aa870503456b3f20349c1df23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejogrb.2023.12.009$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38100938$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ter Welle - Butalid, Maria Elena</creatorcontrib><creatorcontrib>van Osch, Liesbeth</creatorcontrib><creatorcontrib>van Bree, Bo E.</creatorcontrib><creatorcontrib>Vriens, Ingeborg J.H.</creatorcontrib><creatorcontrib>Derhaag, Josien G.</creatorcontrib><creatorcontrib>de Die - Smulders, Christine E.M.</creatorcontrib><creatorcontrib>Tjan - Heijnen, Vivianne C.G.</creatorcontrib><creatorcontrib>van Golde, Ron J.T.</creatorcontrib><title>Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>•First qualitative research of considerations of women after fertility preservation.•Women are strongly motivated to try natural conception after fertility preservation.•Perceived time pressure is an important motivator for embryo transfer.•Wish for pre-implantation genetic testing is a reason for embryo transfer.•Physician’s advice highly influences the decision on mode of conception.
To gain insight into the considerations of breast cancer survivors to return or not for embryo transfer after the use of fertility preservation.
This is a qualitative study with semi-structured interviews. The interviews were planned until saturation of themes had been achieved. Content analysis was used to analyze the data. Sixteen out of 35 approached women took part in this study. Interviews were conducted with women who had oocytes or embryos cryopreserved prior to breast cancer treatment at the Maastricht University Medical Center between 2008 and 2016. All women who had cryopreservation more than two years ago were invited for the interviews. Women who had recurrence of disease were excluded. In the interviews we hypothesized the situation ‘suppose the menses would have been recovered completely’ for women who still had chemotherapy-induced menopause or used an GnRH (Gonadotropin-releasing hormone) analogue.
Most women had a strong intrinsic motivation to pursue natural conception over the use of earlier cryopreserved oocytes or embryos. Time pressure was the most mentioned consideration to use cryopreserved oocytes or embryos. The wish to use pre-implantation genetic testing (PGT) in the presence of a germline BRCA1/2 mutation was another consideration to opt for embryo transfer. Furthermore, the physician’s advice was an important motivation to choose for either natural conception or the use of cryopreserved oocytes or embryos.
Multiple considerations influence women’s decision making on the mode of conception after breast cancer. Although it concerned a single-center study in a highly-selected population, insight into these considerations can help physicians to address these important topics in counseling these women.</description><subject>Breast cancer</subject><subject>Considerations</subject><subject>Evaluation</subject><subject>Fertility preservation</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVISTbb_IMQdMzFrj4sf-QQCEubFgK9tGchy6OgZdfajGSD_3203aTH6CC9Es_MoIeQG85Kznj9bVvCNrxgXwomZMlFyVh3Rla8bUTR1Ko6JysmGS8E5-qSXMW4ZXlJ2V2QS9nyTMt2RZZNGKMfAE3yOdHgaI9gYqLWjBaQxglnPweMNAWKkCYcqQtIYd_jEmhCM0aXOeNS3nNKfufTQg8IEXD-1_aePtLXyeT3fJ2BxjQNy1fyxZldhOv3c03-_vj-Z_OzeP799Gvz-FxYqZpUcNa3Aqq-VsI2TjHoWS34wOuat51SnbFDxaSpjGkbppisVN1LJ3LoLB-ckGtyd-p7wPA6QUx676OF3c6MEKaoRcdEVzeirTJanVCLIUYEpw_o9wYXzZk-StdbfZKuj9I1F_qocU1u3ydM_R6G_0UfljPwcAIg_3P2gDpaD1nv4BFs0kPwn094A7LYls4</recordid><startdate>202402</startdate><enddate>202402</enddate><creator>ter Welle - Butalid, Maria Elena</creator><creator>van Osch, Liesbeth</creator><creator>van Bree, Bo E.</creator><creator>Vriens, Ingeborg J.H.</creator><creator>Derhaag, Josien G.</creator><creator>de Die - Smulders, Christine E.M.</creator><creator>Tjan - Heijnen, Vivianne C.G.</creator><creator>van Golde, Ron J.T.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202402</creationdate><title>Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study</title><author>ter Welle - Butalid, Maria Elena ; van Osch, Liesbeth ; van Bree, Bo E. ; Vriens, Ingeborg J.H. ; Derhaag, Josien G. ; de Die - Smulders, Christine E.M. ; Tjan - Heijnen, Vivianne C.G. ; van Golde, Ron J.T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-10b82e4b652c7f50eb0621d166189559acd403a4aa870503456b3f20349c1df23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Breast cancer</topic><topic>Considerations</topic><topic>Evaluation</topic><topic>Fertility preservation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ter Welle - Butalid, Maria Elena</creatorcontrib><creatorcontrib>van Osch, Liesbeth</creatorcontrib><creatorcontrib>van Bree, Bo E.</creatorcontrib><creatorcontrib>Vriens, Ingeborg J.H.</creatorcontrib><creatorcontrib>Derhaag, Josien G.</creatorcontrib><creatorcontrib>de Die - Smulders, Christine E.M.</creatorcontrib><creatorcontrib>Tjan - Heijnen, Vivianne C.G.</creatorcontrib><creatorcontrib>van Golde, Ron J.T.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ter Welle - Butalid, Maria Elena</au><au>van Osch, Liesbeth</au><au>van Bree, Bo E.</au><au>Vriens, Ingeborg J.H.</au><au>Derhaag, Josien G.</au><au>de Die - Smulders, Christine E.M.</au><au>Tjan - Heijnen, Vivianne C.G.</au><au>van Golde, Ron J.T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2024-02</date><risdate>2024</risdate><volume>293</volume><spage>27</spage><epage>31</epage><pages>27-31</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>•First qualitative research of considerations of women after fertility preservation.•Women are strongly motivated to try natural conception after fertility preservation.•Perceived time pressure is an important motivator for embryo transfer.•Wish for pre-implantation genetic testing is a reason for embryo transfer.•Physician’s advice highly influences the decision on mode of conception.
To gain insight into the considerations of breast cancer survivors to return or not for embryo transfer after the use of fertility preservation.
This is a qualitative study with semi-structured interviews. The interviews were planned until saturation of themes had been achieved. Content analysis was used to analyze the data. Sixteen out of 35 approached women took part in this study. Interviews were conducted with women who had oocytes or embryos cryopreserved prior to breast cancer treatment at the Maastricht University Medical Center between 2008 and 2016. All women who had cryopreservation more than two years ago were invited for the interviews. Women who had recurrence of disease were excluded. In the interviews we hypothesized the situation ‘suppose the menses would have been recovered completely’ for women who still had chemotherapy-induced menopause or used an GnRH (Gonadotropin-releasing hormone) analogue.
Most women had a strong intrinsic motivation to pursue natural conception over the use of earlier cryopreserved oocytes or embryos. Time pressure was the most mentioned consideration to use cryopreserved oocytes or embryos. The wish to use pre-implantation genetic testing (PGT) in the presence of a germline BRCA1/2 mutation was another consideration to opt for embryo transfer. Furthermore, the physician’s advice was an important motivation to choose for either natural conception or the use of cryopreserved oocytes or embryos.
Multiple considerations influence women’s decision making on the mode of conception after breast cancer. Although it concerned a single-center study in a highly-selected population, insight into these considerations can help physicians to address these important topics in counseling these women.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38100938</pmid><doi>10.1016/j.ejogrb.2023.12.009</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-2115 |
ispartof | European journal of obstetrics & gynecology and reproductive biology, 2024-02, Vol.293, p.27-31 |
issn | 0301-2115 1872-7654 |
language | eng |
recordid | cdi_proquest_miscellaneous_2902967284 |
source | ScienceDirect Journals (5 years ago - present) |
subjects | Breast cancer Considerations Evaluation Fertility preservation |
title | Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A50%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Considerations%20of%20breast%20cancer%20survivors%20to%20return%20for%20embryo%20transfer%20after%20fertility%20preservation:%20A%20qualitative%20study&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=ter%20Welle%20-%20Butalid,%20Maria%20Elena&rft.date=2024-02&rft.volume=293&rft.spage=27&rft.epage=31&rft.pages=27-31&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2023.12.009&rft_dat=%3Cproquest_cross%3E2902967284%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2902967284&rft_id=info:pmid/38100938&rft_els_id=S0301211523008539&rfr_iscdi=true |